(See also Overview of Movement and Cerebellar Disorders.)
The cerebellum has 3 parts:
Archicerebellum (vestibulocerebellum): It includes the flocculonodular lobe, which is located in the medial zone. The archicerebellum helps maintain equilibrium and coordinate eye, head, and neck movements; it is closely interconnected with the vestibular nuclei.
Midline vermis (paleocerebellum): It helps coordinate trunk and leg movements. Vermis lesions result in abnormalities of stance and gait.
Lateral hemispheres (neocerebellum): They control quick and finely coordinated limb movements, predominantly of the arms.
There is growing consensus that in addition to coordination, the cerebellum controls some aspects of memory, learning, and cognition.
Ataxia is the archetypal sign of cerebellar dysfunction, but many other motor abnormalities may occur (see table Signs of Cerebellar Disorders).
Signs of Cerebellar Disorders
The most common cause of cerebellar disorders is
Such malformations are almost always sporadic, often occurring as part of complex malformation syndromes (eg, Dandy-Walker malformation) that affect other parts of the central nervous system (CNS).
Malformations manifest early in life and are nonprogressive. Manifestations vary markedly depending on the structures involved; ataxia is usually present.
Hereditary ataxias may be autosomal recessive or autosomal dominant. Autosomal recessive ataxias include Friedreich ataxia (the most prevalent), ataxia-telangiectasia, abetalipoproteinemia, ataxia with isolated vitamin E deficiency, and cerebrotendinous xanthomatosis.
Friedreich ataxia results from a gene mutation causing abnormal repetition of the DNA sequence GAA in the FXN gene on the long arm of chromosome 9; the FXN gene codes for the mitochondrial protein frataxin. The GAA sequence is repeated 5 to 38 times within the FXN gene in people who do not have Friedreich ataxia; however, in people with Friedreich ataxia, the GAA sequence may be repeated 70 to > 1000 times (1). Inheritance is autosomal recessive. Decreased frataxin levels lead to mitochondrial iron overload and impaired mitochondrial function.
In Friedreich ataxia, gait unsteadiness begins between ages 5 and 15; it is followed by upper-extremity ataxia, dysarthria, and paresis, particularly of the lower extremities. Mental function often declines. Tremor, if present, is slight. Reflexes and vibration and position senses are lost. Talipes equinovarus (clubfoot), scoliosis, and progressive cardiomyopathy are common. By their late 20s, patients may be confined to a wheelchair. Death, often due to arrhythmia or heart failure, usually occurs by middle age.
Spinocerebellar ataxias (SCAs) are the main autosomal dominant ataxias. Classification of these ataxias has been revised many times recently as knowledge about genetics increases. Currently, at least 43 different gene loci are recognized; about 10 involve expanded DNA sequence repeats. Some involve a repetition of the DNA sequence CAG that codes for the amino acid glutamine, similar to that in Huntington disease.
Manifestations of SCAs vary. Some of the most common SCAs affect multiple areas in the central and peripheral nervous systems; neuropathy, pyramidal signs, and restless leg syndrome, as well as ataxia, are common. Some SCAs usually cause only cerebellar ataxia.
Acquired ataxias may result from nonhereditary neurodegenerative disorders (eg, multiple system atrophy), systemic disorders, multiple sclerosis, cerebellar strokes, repeated traumatic brain injury, or toxin exposure, or they may be idiopathic. Systemic disorders include alcoholism (alcoholic cerebellar degeneration), thiamin deficiency, celiac disease, heatstroke, hypothyroidism, and vitamin E deficiency.
Toxins that can cause cerebellar dysfunction include carbon monoxide, heavy metals, lithium, phenytoin, and certain solvents. Toxic levels of certain drugs (eg, antiseizure drugs, sedatives in high doses) can cause cerebellar dysfunction and ataxia.
Rarely, subacute cerebellar degeneration occurs as a paraneoplastic syndrome in patients with breast cancer, ovarian cancer, small cell carcinoma of the lung, or other solid tumors. Cerebellar degeneration may precede the discovery of the cancer by weeks to years. Anti-Yo, now called PCA-1 (Purkinje cell cytoplasmic antibody type 1) is a circulating autoantibody that occurs in the serum or cerebrospinal fluid (CSF) of some patients, especially women with breast or ovarian cancer.
In children, primary brain tumors (medulloblastoma, cystic astrocytoma) may be the cause; the midline cerebellum is the most common site of such tumors. Rarely, in children, reversible diffuse cerebellar dysfunction follows viral infections.
Some systemic disorders (eg, hypothyroidism, celiac disease) and toxin exposure can be treated; occasionally, surgery for structural lesions (tumor, hydrocephalus) is beneficial. However, treatment is usually only supportive (eg, exercises to improve balance, posture, and coordination; devices to help with walking, eating, and other daily activities).
1. Zesiewicz TA, Wilmot G, Kuo SH, et al: Comprehensive systematic review summary: Treatment of cerebellar motor dysfunction and ataxia. Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology 90 (10):464–471, 2018. doi: 10.1212/WNL.0000000000005055.
Drugs Mentioned In This Article
|Drug Name||Select Trade|